Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

AL Amyloidosis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • CTCA at Western Regional Medical Center, Goodyear, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · 623-207-3000
    Contact: Principal Investigator (Tibor J. Kovacsovics)
  • Banner University Medical Center - Tucson, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Muhammad Husnain)
  • University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Muhammad Husnain)
  • City of Hope Comprehensive Cancer Center, Duarte, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Michael A. Rosenzweig)
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Polina Bellman)
  • City of Hope at Irvine Lennar, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-467-3411
    Contact: Principal Investigator (Michael A. Rosenzweig)
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Polina Bellman)
  • Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Terri L. Parker)
  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Terri L. Parker)
  • Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Terri L. Parker)
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Terri L. Parker)
  • Yale University, New Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Terri L. Parker)
  • Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Terri L. Parker)
  • Smilow Cancer Hospital Care Center at Long Ridge, Stamford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Terri L. Parker)
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Terri L. Parker)
  • MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-444-2223
    Contact: Principal Investigator (Kimberley Doucette)
  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 954-461-2180
    Contact: Principal Investigator (James E. Hoffman)
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (James E. Hoffman)
  • UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (James E. Hoffman)
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (James E. Hoffman)
  • UM Sylvester Comprehensive Cancer Center at Hollywood, Hollywood, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (James E. Hoffman)
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (James E. Hoffman)
  • UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (James E. Hoffman)
  • University of Miami Sylvester Comprehensive Cancer Center at Sole Mia, North Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · kginnity@med.miami.edu
    Contact: Principal Investigator (James E. Hoffman)
  • UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (James E. Hoffman)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Jonathan L. Kaufman)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Jonathan L. Kaufman)
  • Rush-Copley Medical Center, Aurora, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · RCMC_Cancer_Research@rush.edu · 630-978-6212
    Contact: Principal Investigator (Priyank P. Patel)
  • University of Illinois, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-355-3046
    Contact: Principal Investigator (Ana Maria Avila Rodriguez)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Priyank P. Patel)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Priyank P. Patel)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Priyank P. Patel)
  • Loyola University Medical Center, Maywood, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 708-226-4357
    Contact: Principal Investigator (Patrick A. Hagen)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Priyank P. Patel)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • University of Kansas Cancer Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Muhammad Umair Mushtaq)
  • University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Muhammad Umair Mushtaq)
  • Walter Reed National Military Medical Center, Bethesda, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 301-319-2100
    Contact: Principal Investigator (Christin Destefano)
  • Boston Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 617-638-8265
    Contact: Principal Investigator (Vaishali Sanchorawala)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CancerAnswerLine@med.umich.edu · 800-865-1125
    Contact: Principal Investigator (Matthew J. Pianko)
  • Henry Ford Cancer Institute-Downriver, Brownstown, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Philip Kuriakose)
  • Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Philip Kuriakose)
  • Henry Ford Medical Center-Fairlane, Dearborn, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Philip Kuriakose)
  • Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Andrew Kin)
  • Henry Ford Hospital, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Philip Kuriakose)
  • Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Andrew Kin)
  • Allegiance Health, Jackson, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Philip Kuriakose)
  • Karmanos Cancer Institute at McLaren Greater Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Andrew Kin)
  • Henry Ford Medical Center-Columbus, Novi, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Philip Kuriakose)
  • Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Philip Kuriakose)
  • Henry Ford Wyandotte Hospital, Wyandotte, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · nhay@hfhs.org
    Contact: Principal Investigator (Philip Kuriakose)
  • Mercy Hospital, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Fairview Southdale Hospital, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Taxiarchis Kourelis)
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • United Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Baptist Memorial Hospital and Cancer Center-Oxford, Oxford, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Brion V. Randolph)
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Brion V. Randolph)
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Keith E. Stockerl-Goldstein)
  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Keith E. Stockerl-Goldstein)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Keith E. Stockerl-Goldstein)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Keith E. Stockerl-Goldstein)
  • Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Keith E. Stockerl-Goldstein)
  • Nebraska Medicine-Bellevue, Bellevue, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Sarah A. Holstein)
  • Nebraska Medicine-Village Pointe, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-559-5600
    Contact: Principal Investigator (Sarah A. Holstein)
  • University of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Sarah A. Holstein)
  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Heather J. Landau)
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Heather J. Landau)
  • Memorial Sloan Kettering Commack, Commack, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Heather J. Landau)
  • Memorial Sloan Kettering Westchester, Harrison, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Heather J. Landau)
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162
    Contact: Principal Investigator (Rajshekhar Chakraborty)
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Heather J. Landau)
  • University of Rochester, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · 585-275-5830
    Contact: Principal Investigator (Frank C. Passero)
  • Novant Health Presbyterian Medical Center, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kashah@novanthealth.org · 980-201-6360
    Contact: Principal Investigator (Raymond Thertulien)
  • Duke University Medical Center, Durham, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-275-3853
    Contact: Principal Investigator (Cristiana C. Chase)
  • Novant Health Cancer Institute - Huntersville, Huntersville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kashah@novanthealth.org · 980-201-6360
    Contact: Principal Investigator (Raymond Thertulien)
  • Novant Health Cancer Institute - Mooresville, Mooresville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kashah@novanthealth.org · 980-201-6360
    Contact: Principal Investigator (Raymond Thertulien)
  • Novant Health Forsyth Medical Center, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · pjordan@novanthealth.org · 336-718-8335
    Contact: Principal Investigator (Franklin L. Chen)
  • Case Western Reserve University, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Timothy E. O'brien)
  • Riverside Methodist Hospital, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jennifer.Sexton@ohiohealth.com · 614-788-3860
    Contact: Principal Investigator (Yvonne A. Efebera)
  • Providence Newberg Medical Center, Newberg, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Charles W. Drescher)
  • Providence Willamette Falls Medical Center, Oregon City, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Charles W. Drescher)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Charles W. Drescher)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Charles W. Drescher)
  • Oregon Health and Science University, Portland, Oregon, United States

  • Geisinger Medical Center, Danville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Joseph P. Lynch)
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · PMCancerResearch@pennmedicine.upenn.edu · 215-349-8245
    Contact: Principal Investigator (Adam Waxman)
  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Adam F. Binder)
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Joseph P. Lynch)
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Brion V. Randolph)
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Brion V. Randolph)
  • Houston Methodist San Jacinto Hospital, Baytown, Texas, United States

    Contact: Study coordinator (Site Public Contact) · protocols@swog.org
    Contact: Principal Investigator (Carrie H. Yuen)
  • Houston Methodist Cypress Hospital, Cypress, Texas, United States

    Contact: Study coordinator (Site Public Contact) · irb@houstonmethodist.org · 346-356-1413
    Contact: Principal Investigator (Carrie H. Yuen)
  • Houston Methodist Hospital, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 713-790-2700
    Contact: Principal Investigator (Carrie H. Yuen)
  • M D Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · askmdanderson@mdanderson.org · 877-632-6789
    Contact: Principal Investigator (Jing Christine Ye)
  • Methodist Willowbrook Hospital, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · protocols@swog.org
    Contact: Principal Investigator (Carrie H. Yuen)
  • Houston Methodist West Hospital, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 832-522-2873
    Contact: Principal Investigator (Carrie H. Yuen)
  • Houston Methodist Saint John Hospital, Nassau Bay, Texas, United States

    Contact: Study coordinator (Site Public Contact) · protocols@swog.org
    Contact: Principal Investigator (Carrie H. Yuen)
  • Houston Methodist Sugar Land Hospital, Sugar Land, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 281-242-2873
    Contact: Principal Investigator (Carrie H. Yuen)
  • Houston Methodist The Woodlands Hospital, The Woodlands, Texas, United States

    Contact: Study coordinator (Site Public Contact) · hmthewoodlands@houstonmethodist.org · 713-790-2700
    Contact: Principal Investigator (Carrie H. Yuen)
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · cancerctr@gundersenhealth.org · 608-775-2385
    Contact: Principal Investigator (David E. Marinier)
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Matthew J. Brunner)
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Matthew J. Brunner)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (Anita D'Souza)
  • Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Sheboygan Physicians Group, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
מובילי המחקר
  • Patrick A Hagen

    Principal Investigator

    SWOG Cancer Research Network